Sunshine Biopharma Inc. and Nora Pharma Inc. have reached a settlement agreement with Chamoun, resolving all claims and disputes related to Chamoun's tenure as President of Nora and the subsequent sale of his shares to Sunshine.

US · 2026-07-10

1. Step 1 · The triggerSunshine Biopharma and Nora Pharma settle all claims with Chamoun, ending legal disputes.
2. Step 2 · Knock-onRemoval of legal uncertainty reduces management distraction and potential financial liability.
3. Step 3 · Reaches youCleaner governance and reduced risk profile may improve investor confidence and access to capital for Sunshine Biopharma.

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: SEC EDGAR — Current filings

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.